July 26, 2021

EuropaBio response to the European Commission Public Consultation on the Regulation for Orphan Medicinal Products and Paediatrics: the value brought by the technology to patients and society should be well recognised

July 20, 2021

EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare

July 3, 2021

EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years

We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them.
June 16, 2021

EPSCO Council conclusions: EuropaBio calls for more pragmatic approach addressing access, availability and affordability of medicines

June 14, 2021

European Biotech Week 2021: EuropaBio invites national biotech communities to celebrate science and innovation

June 7, 2021

EuropaBio invited healthcare biotech SMEs to learn about EU Policy Priorities

June 7, 2021

Pragmatic IP solutions and strong collaborations will ensure faster global access to vaccines

June 1, 2021

EFIB 2021 launch event: biotech community discussed innovation solutions for a sustainable future

May 27, 2021

EuropaBio welcomes the EU strategy on Covid-19 therapeutics

May 27, 2021

EuropaBio meets EMA to exchange views on topics of common interest

2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 1 & 2 2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 4 & 5
May 25, 2021

Alliance for Regenerative Medicine, European Federation of Pharmaceutical Industries and Associations, and European Association for Bioindustries Call for Advanced Therapies to be Exempt from EU GMO Legislation

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
May 20, 2021

Advanced Therapies bring tranformational value to European patients

May 12, 2021

EuropaBio celebrated its inaugural National Associations Council Summit: Collaborations and trust are vital to build a responsive and competetive biotech sector in Europe

IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge. In the long run, the waiver proposal undermines the existing vaccine eco-system built in the crisis urgency.
May 3, 2021

EuropaBio launches a new Biopharmaceutical Strategy Group

April 28, 2021

The Lithuanian Biotechnology Association joins EuropaBio: it’s time to put Lithuania on a map of the most biotech savvy nations

EuropaBio is delighted to announce that the Lithuanian Biotechnology Association joins EuropaBio
Become a member